JOINT-STOCK COMPANY "ROSNANO" sold a share in companies on production HIV medicine
JOINT-STOCK COMPANY "ROSNANO" sold 33,33% of LLC "Nanolek", the producer of drugs for HIV, for 2,35 billion rubles to shareholder companies. According to the source, actions belong to the Cyprian Nanolek Holding ltd and its final beneficiary to Khristenko Vladimir, to general director to Nekrasov Mikhail, to Weinstein Eugenie and to Andrey Reus...